Company research
AdaptHealth Corp.
CIK 1725255Updated Sep 27, 2026
SecurityAHCO · NASDAQ · equity
Historical securities (2)
AHCOW · OTC · warrant · closed Dec 6, 2019DFBHW · NASDAQ · warrant · closed Nov 11, 2019Name history
DFB Healthcare Acquisitions Corp. · through Nov 8, 2019
AHCO price & chart
Loading TradingView…
NASDAQ:AHCO on TradingView ↗About the company
AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including CPAP and BiLevel services) to individuals for the treatment of obstructive sleep apnea. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. The Diabetes Health segment provides medical devices, including continuous glucose monitors and insulin pumps, and related services to patients for the treatment of diabetes. The Wellness at Home segment provides home medical equipment and services to patients in their homes including those who have been discharged from acute care and other facilities. The segment tailors a service…
In the news
AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC ↗
Cardinal Health expands home care business with two tuck-in acquisitions ↗
HALPER SADEH LLC ENCOURAGES ADAPTHEALTH CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS News provided by Halper Sadeh LLP Dec 05, 2025, 15:30 ET Share this article Share to X Share this article Share to X Shareholders should contact the firm immediately as there may be limited time to ↗
Seeking Alpha
10 small-cap U.S. healthcare stocks with the weakest momentum grades ↗
AdaptHealth appoints Harriss Currie as CFO ↗
AdaptHealth: Fixed-Price Contracts Create Too Much Risk ↗
SEC disclosures
AdaptHealth Corp. files 8-K: Material Event ↗
Recent filings
3 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
4/A filing
4 filing
4 filing
Show 5 more recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Regulation FD Disclosure
Items 7.01
Material Cybersecurity Incidents
Items 1.05
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 4,316,577,000Source | 4,486,947,000Source | 4,508,650,000Source | 5,219,587,000Source |
| Property, Plant and EquipmentUSD | 503,193,000Source | 474,556,000Source | 495,101,000Source | — |
| GoodwillUSD | 2,541,428,000Source | 2,675,166,000Source | 2,724,958,000Source | 3,545,297,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 85,121,000Source | 105,548,000Source | 130,160,000Source | 162,773,000Source |
| Current assets: | ||||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 370,897,000Source | 408,019,000Source | 388,910,000Source | 359,146,000Source |
| Inventory, NetUSD | 151,247,000Source | 139,842,000Source | 113,642,000Source | 127,754,000Source |
| Assets, CurrentUSD | 728,899,000Source | 755,788,000Source | 649,022,000Source | 585,308,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 100,619,000Source | 45,432,000Source | 69,338,000Source | 52,136,000Source |
| Operating Lease, Right-of-Use AssetUSD | 111,968,000Source | 105,999,000Source | 110,465,000Source | 129,506,000Source |
| Other Assets, NoncurrentUSD | 19,119,000Source | 17,584,000Source | 21,128,000Source | 22,415,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,790,253,000Source | 2,908,829,000Source | 3,041,981,000Source | 3,061,829,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 1,000Source | 1,000Source | 1,000Source | 1,000Source |
| Common Stock, Value, IssuedUSD | 13,000Source | 13,000Source | 13,000Source | 13,000Source |
| Additional Paid in CapitalUSD | 2,176,990,000Source | 2,156,604,000Source | 2,149,951,000Source | 2,130,148,000Source |
| Retained Earnings (Accumulated Deficit)USD | -632,972,000Source | -562,178,000Source | -652,600,000Source | 26,295,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 78,000Source | 2,253,000Source | 4,356,000Source | 8,693,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,518,562,000Source | 1,571,145,000Source | 1,458,454,000Source | 2,151,158,000Source |
| Liabilities and EquityUSD | 4,316,577,000Source | 4,486,947,000Source | 4,508,650,000Source | 5,219,587,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 712,392,000Source | 566,987,000Source | 536,999,000Source | 456,214,000Source |
| Operating Lease, Liability, CurrentUSD | 30,728,000Source | 29,945,000Source | 29,270,000Source | 30,001,000Source |
| Accounts Payable, CurrentUSD | 352,381,000Source | 284,602,000Source | 211,504,000Source | 222,505,000Source |
| Operating Lease, Liability, NoncurrentUSD | 85,470,000Source | 80,275,000Source | 85,529,000Source | 104,394,000Source |
| Other Liabilities, NoncurrentUSD | 243,804,000Source | 272,016,000Source | 302,093,000Source | 305,501,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 7,762,000Source | 6,973,000Source | 8,215,000Source | 6,600,000Source |
| Additional Financial Items | ||||
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 20,313,000Source | 16,250,000Source | 53,368,000Source | 35,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 1,715,983,000Source | 1,964,921,000Source | 2,094,614,000Source | 2,153,267,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -66,038,000Source | 94,780,000Source | -674,780,000Source | 73,133,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 381,927,000Source | 365,334,000Source | 382,783,000Source | 351,178,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 21,876,000Source | 14,880,000Source | 22,468,000Source | 22,397,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -30,986,000Source | 26,217,000Source | 28,862,000Source | 209,000Source |
| Increase (Decrease) in InventoriesUSD | 11,491,000Source | 28,065,000Source | -15,531,000Source | 6,300,000Source |
| Deferred Income Tax Expense (Benefit)USD | 47,163,000Source | 32,049,000Source | -62,595,000Source | 18,036,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 601,771,000Source | 541,839,000Source | 480,666,000Source | 373,867,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 42,378,000Source | 9,536,000Source | 19,687,000Source | 19,017,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -303,190,000Source | -310,275,000Source | -357,278,000Source | -411,171,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 382,388,000Source | 306,055,000Source | 337,463,000Source | 391,423,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 2,701,000Source | 2,066,000Source | 5,843,000Source | 3,516,000Source |
| Payments for Repurchase of Common StockUSD | 0Source | 0Source | 29,275,000Source | 13,992,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -302,192,000Source | -198,949,000Source | -92,528,000Source | -66,051,000Source |
| Repayments of Long-term DebtUSD | 250,000,000Source | 423,477,000Source | 95,000,000Source | 20,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -3,611,000Source | 32,615,000Source | 30,860,000Source | -103,355,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 106,136,000Source | 109,747,000Source | 77,132,000Source | 46,272,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 101,243,000Source | 122,072,000Source | 126,228,000Source | 108,885,000Source |
| Income Taxes Paid, NetUSD | 24,283,000Source | 14,139,000Source | 14,756,000Source | 14,949,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 21,876,000Source | 14,880,000Source | 22,468,000Source | 22,400,000Source |
| Amortization of Debt Issuance CostsUSD | 5,694,000Source | 5,666,000Source | 5,234,000Source | 5,234,000Source |
| Amortization of Intangible AssetsUSD | 20,300,000Source | 22,300,000Source | 32,600,000Source | 40,000,000Source |
| DepreciationUSD | 361,600,000Source | 343,100,000Source | 350,200,000Source | 311,200,000Source |
| Gain (Loss) on Disposition of BusinessUSD | 32,602,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | -2,273,000Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | 382,293,000Source | 359,238,000Source | 190,091,000Source | 162,125,000Source |
| GoodwillUSD | 2,541,428,000Source | 2,675,166,000Source | 2,724,958,000Source | 3,545,297,000Source |
| Goodwill, Impairment LossUSD | 127,995,000Source | 13,078,000Source | 830,787,000Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 50,884,000Source | 41,239,000Source | -49,004,000Source | 24,769,000Source |
| Net Income (Loss) Attributable to ParentUSD | -70,794,000Source | 90,422,000Source | -678,895,000Source | 69,316,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 4,756,000Source | 4,358,000Source | 4,115,000Source | 3,817,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -70,794,000Source | 82,747,000Source | -678,895,000Source | 63,449,000Source |
| Other Nonoperating Income (Expense)USD | -274,000Source | -2,793,000Source | -29,566,000Source | -253,000Source |
| Payments of Financing CostsUSD | 0Source | 6,429,000Source | 0Source | 0Source |
| Proceeds from Issuance of Common StockUSD | — | — | 0Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | 0Source | 742,000Source | 587,000Source | 2,510,000Source |
| Unrealized Gain (Loss) on DerivativesUSD | 0Source | 367,000Source | 1,801,000Source | 2,936,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 3,244,857,000Source | 3,260,975,000Source | 3,200,177,000Source | 2,970,595,000Source |
| Cost of RevenueUSD | 2,635,658,000Source | 2,579,882,000Source | 2,720,613,000Source | 2,553,169,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | 90,873,000Source | 263,732,000Source | -598,401,000Source | 190,411,000Source |
| Other Nonoperating Income (Expense)USD | -274,000Source | -2,793,000Source | -29,566,000Source | -253,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -15,154,000Source | 136,019,000Source | -723,784,000Source | 97,902,000Source |
| Income Tax Expense (Benefit)USD | 50,884,000Source | 41,239,000Source | -49,004,000Source | 24,769,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 4,756,000Source | 4,358,000Source | 4,115,000Source | 3,817,000Source |
| Net Income (Loss) Attributable to ParentUSD | -70,794,000Source | 90,422,000Source | -678,895,000Source | 69,316,000Source |
| Earnings Per Share, BasicUSD per share | -0.52Source | 0.62Source | -5.06Source | 0.47Source |
| Earnings Per Share, DilutedUSD per share | -0.52Source | 0.61Source | -5.31Source | 0.33Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 135,146,000Source | 133,756,000Source | 134,156,000Source | 134,175,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 135,146,000Source | 135,531,000Source | 134,418,000Source | 138,988,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 20,300,000Source | 22,300,000Source | 32,600,000Source | 40,000,000Source |
| Costs and ExpensesUSD | 3,186,586,000Source | 2,997,243,000Source | 3,798,578,000Source | 2,780,184,000Source |
| General and Administrative ExpenseUSD | 382,293,000Source | 359,238,000Source | 190,091,000Source | 162,125,000Source |
| Goodwill, Impairment LossUSD | 127,995,000Source | 13,078,000Source | 830,787,000Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -15,154,000Source | — | — | — |
| Interest ExpenseUSD | — | — | 130,299,000Source | 109,414,000Source |
| Interest Expense, DebtUSD | 103,600,000Source | 124,700,000Source | 131,000,000Source | 112,400,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -105,753,000Source | -126,668,000Source | — | — |
| Labor and Related ExpenseUSD | 165,800,000Source | 157,200,000Source | 68,300,000Source | 60,600,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -70,794,000Source | 82,747,000Source | -678,895,000Source | 63,449,000Source |
| Other Cost of Operating RevenueUSD | 175,248,000Source | 168,960,000Source | 236,039,000Source | 225,719,000Source |
| Reclassification from AOCI, Current Period, before Tax, Attributable to ParentUSD | — | 400,000Source | 1,800,000Source | 2,900,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | 0Source | 7,675,000Source | 0Source | 5,867,000Source |
Filing attachments
tm2624956d1_ex99-1.htm · 8-K · 2026-09-08
EX-99.1 3 tm2624956d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE AdaptHealth Appoints Harriss Currie as Chief Financial Officer PLYMOUTH MEETING, Pa. - September 8th 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. C…
Read attachment ↗ahco-20260804x8k_ex991.htm · 8-K · 2026-08-04
EX-99.1 2 ahco-20260804x8k_ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2026 RESULTS CONSHOHOCKEN, Pa. - August 4, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2026. Second Quart…
Read attachment ↗tm2620877d1_ex99-1.htm · 8-K · 2026-07-20
EX-99.1 3 tm2620877d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE AdaptHealth Corp Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businesses Sharpens strategic focus on businesses where the Company crosses the threshold of the home to deliver clinical value to patients …
Read attachment ↗ahco-20260505x8k_ex991.htm · 8-K · 2026-05-05
EX-99.1 2 ahco-20260505x8k_ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2026 RESULTS CONSHOHOCKEN, Pa. - May 5, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2026. First Quarter Bu…
Read attachment ↗